MEDADVISOR LTD

ASX: MDR (MEDADVISOR FPO [MDR])

Last update: 9 hours ago

0.028

0.00 (0.00%)

Previous Close 0.028
Open 0.029
Volume 664,072
Avg. Volume (3M) 500,621
Market Cap 17,705,482
Price / Sales 0.420
Price / Book 3.95
52 Weeks Range
0.027 (-3%) — 0.380 (1257%)
Earnings Date 26 Aug 2025 - 1 Sep 2025
Profit Margin -4.51%
Operating Margin (TTM) 5.27%
Diluted EPS (TTM) -0.010
Quarterly Revenue Growth (YOY) -24.40%
Quarterly Earnings Growth (YOY) -79.60%
Total Debt/Equity (MRQ) 33.53%
Current Ratio (MRQ) 1.25
Operating Cash Flow (TTM) -11.98 M
Levered Free Cash Flow (TTM) -10.08 M
Return on Assets (TTM) -1.35%
Return on Equity (TTM) -8.34%

Market Trend

Short Term Medium Term
Industry Health Information Services (AU) Mixed Mixed
Health Information Services (Global) Bullish Mixed
Stock MEDADVISOR FPO [MDR] - -

AIStockmoo Score

0.6
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average 0.63

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MDR 18 M - - 3.95
AYA 117 M - - 16.75
BMT 62 M - - 1.56
PHX 60 M - - 4.88
PME 32 B 0.15% 275.26 127.71
CGS 311 M - 19.83 5.51

MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.

Sector Healthcare
Industry Health Information Services
Investment Style Small Core
% Held by Insiders 36.99%
% Held by Institutions 33.46%

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria